IBAC on Nasdaq

IB Acquisition Corp.

IB Acquisition Corp. is an American commercial physical and biological research services company.1 It is headquartered in Boca Raton, Florida.1 Its shares trade on Nasdaq under the symbol IBAC.1

Price unavailable

Last updated Oct 20, 2026.

Overview

$3.4MNet income, fiscal 20252

Compare with another stock.

  • TickerIBAC on Nasdaq1
  • IndustryServices-Commercial Physical & Biological Research1
  • HeadquartersBoca Raton, Florida1
  • Incorporated inNV3
  • Business address2500 N Military Trail, Suite 160-A, Boca Raton, Fl 334313
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Services, former partner with Calabrese Consulting (which acquired Albeck Financial Services in March 2022).4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income52-$748.9K in 2025+10843% since 2023
-$800.0K-$600.0K-$400.0K-$200.0K02023: -$6.8K-$6.8K20232024: -$524.0K-$524.0K2024+7556%2025: -$748.9K-$748.9K2025+43%
Net income52$3.4M in 2025
-$1.0M0$1.0M$2.0M$3.0M$4.0M2023: -$6.8K-$6.8K20232024: $1.9M$1.9M20242025: $3.4M$3.4M2025+83%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-09-302024-09-30
General and administrative expenses$748.9K$524.0K
Loss from operations-$748.9K-$524.0K
Interest and dividends earned on cash and investments held in Trust Account$5.1M$3.0M
Other income$5.1M$3.0M
Income before provision for income taxes$4.4M$2.5M
Provision for income taxes-$965.6K-$635.5K
Net income$3.4M$1.9M

Compare IB Acquisition Corp. with another company

Corporate structure

IB Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of IB Acquisition Corp.

  • AQR CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Apr 8, 2026 (4 filings since Nov 14, 2024)
  • Bank of Montreal Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Feb 12, 2026 (2 filings since Nov 13, 2025)
  • Barclays Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Feb 11, 2026 (2 filings since Nov 12, 2025)
  • TD SECURITIES (USA) LLC Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Nov 14, 2025 (2 filings since Aug 12, 2025)
  • Karpus Management, Inc. Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Nov 7, 2025 (2 filings since Aug 8, 2024)
  • Wealthspring Capital LLC Filed SCHEDULE 13G/A on IB Acquisition Corp., latest Oct 14, 2025 (2 filings since Nov 14, 2024)
  • METEORA CAPITAL, LLC Filed SCHEDULE 13G on IB Acquisition Corp., latest Feb 14, 2025
  • James Michael McCrory Filed SC 13D on IB Acquisition Corp., latest Apr 11, 2024
  • I-B Good Works 4, LLC Filed SC 13D on IB Acquisition Corp., latest Apr 8, 2024
  • IB Acquisition Corp. Boca Raton, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What IB Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$428.7K2 Sep 30, 2025$822.8K2 Sep 30, 2024−47.9%

Properties, in its own words

We currently maintain our executive offices at 2500 N Military Trail, Suite 160-A, Boca Raton, FL 33431. Previously, the cost for this space is included in the $5,000 per month fee that was paid to Christy Albeck, our Chief Financial Officer, for office space, utilities, secretarial support and other administrative and consulting services. We believe that the amount we will pay under the administrative services agreement is comparable to the cost of similar services that we could obtain from unaffiliated persons. We consider our current office space adequate for our current operations.

Item 2 of the 10-K filed Dec 29, 2025.4

Leadership

Who has led IB Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Adelmo S. Lopez2024
2025
Board members and other officers (3)

Timeline

  1. Oct 15, 20268-K Director nominations; Other events11
  2. Oct 6, 20268-K Listing notice or transfer12
  3. Sep 30, 20268-K Bylaws or fiscal year changed; Shareholder vote13
  4. Sep 23, 20268-K Entered a material agreement; Unregistered sale of shares14
  5. Sep 21, 20268-K Entered a material agreement15
  6. Mar 27, 20268-K Entered a material agreement; Bylaws or fiscal year changed16
  7. Mar 26, 20268-K Shareholder vote17
  8. Mar 18, 20268-K Other events18
  9. Mar 16, 20268-K Entered a material agreement; Regulation FD disclosure19
  10. Sep 24, 20258-K Entered a material agreement; Bylaws or fiscal year changed; Shareholder vote20
  11. May 13, 20248-K Change of auditor21
  12. Apr 26, 20248-K Change of auditor22
  13. Mar 25, 2024New chief executive Adelmo S. Lopez becomes CEO8

Filings

88 filings to the SEC since October 2021: 2 annual reports, 8 quarterly reports, 15 major events, 14 insider forms, 17 large holders, 32 other. The latest 20:

  1. Oct 15, 20268-K EDGAR
  2. Oct 6, 20268-K EDGAR
  3. Sep 30, 20268-K EDGAR
  4. Sep 23, 20268-K/A EDGAR
  5. Sep 23, 2026425 EDGAR
  6. Sep 23, 2026425 EDGAR
  7. Sep 21, 2026425 EDGAR
  8. Sep 21, 20268-K EDGAR
  9. Sep 4, 2026DEF 14A EDGAR
  10. Aug 25, 2026PRE 14A EDGAR
  11. Aug 14, 202610-Q EDGAR
  12. Jul 24, 2026S-4 EDGAR
  13. May 15, 202610-Q EDGAR
  14. Apr 17, 2026425 EDGAR
  15. Apr 8, 2026SCHEDULE 13G/A EDGAR
  16. Mar 27, 20268-K EDGAR
  17. Mar 26, 20268-K EDGAR
  18. Mar 25, 20264 EDGAR
  19. Mar 24, 20264 PRIMARY DOCUMENT EDGAR
  20. Mar 18, 2026425 EDGAR

The 88 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 0 buys and 7 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 23, 2026AQR Arbitrage LLC10% ownerSale335,000$10.80$3.6MForm 4
Mar 20, 2026AQR CAPITAL MANAGEMENT LLC10% ownerSale4,619$10.75$49.7KForm 4
Oct 9, 2025AQR Arbitrage LLC10% ownerSale195,806$10.44$2.0MForm 4
Oct 2, 2025AQR Arbitrage LLC10% ownerSale4,400$10.50$46.2KForm 4
Oct 1, 2025AQR Capital Management Holdings, LLC10% ownerSale29,821$10.50$313.1KForm 4
Sep 30, 2025AQR Capital Management Holdings, LLC10% ownerSale72,664$10.51$763.7KForm 4
Sep 29, 2025AQR Capital Management Holdings, LLC10% ownerSale122,309$10.50$1.3MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Jane Street Group, LLC20,436$220.3K0.0%+63
Clear Street Group Inc.16,807$181.2K0.0%+1,807
Morgan Stanley45$4850.0%−6
Hrt Financial LP37,901$4050.0%+954
Flow Traders U.s. LLC20,803$2240.0%−3,170

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How IB Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARIB Acquisition Corp.1
  • CIK0001998781
  • Employer ID (EIN)85-29467844
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inNevada4
  • Fiscal year endsSeptember 301
  • Industry code (SIC)8731 Services-Commercial Physical & Biological Research1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address2500 N Military Trail, Suite 160-A, Boca Raton, FL 334311
  • Phone214-687-00201
  • Shares outstanding5,008,229 as of Aug 14, 20267
  • Public float$14.8M as of Mar 31, 20254
  • AuditorMaloneBailey LLP, Houston, Texas PCAOB ID 206; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 17, 20231
  • Filings88 in all: 8-K (13), 10-Q (8), SCHEDULE 13G/A (8), 3 (7), 4 (7), 425 (6), CORRESP (6), SCHEDULE 13G (4)1
    All 24 form types

    DEF 14A (3), PRE 14A (3), S-1/A (3), SC 13G (3), UPLOAD (3), 10-K (2), 8-K/A (2), SC 13D (2), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DEFR14A (1), EFFECT (1), S-1 (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Dec 29, 2025
    Quarterly report (10-Q) Aug 14, 2026
    Proxy statement (DEF 14A) Sep 4, 2026
    Latest 8-K (8-K) Oct 15, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.0001 per shareIBACThe NASDAQ Stock Market LLC
Rights, each right convertible into one-twentieth of one share of common stockIBACRThe NASDAQ Stock Market LLC

From the cover page of the 10-K filed Dec 29, 2025 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks IB Acquisition Corp. names in Item 1A of its 10-K filed Dec 29, 2025: 77 risks under these headings, as written.4

  • Risks Relating to Our Search For, Consummation of, or Inability to Consummate, a Business Combination
  • As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive target businesses. This could increase the cost of our initial business combination and could even result in our inability to find a suitable target business or to consummate an initial business combination.
  • We have engaged our underwriters to provide services to us, and we may engage our underwriters or one of their respective affiliates to provide additional services to us, which may include acting as financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. These financial incentives will cause our underwriters to have potential conflicts of interest in rendering any such additional services to us, including, for example, in connection with the sourcing and consummation of an initial business combination.
  • We may not be able to complete an initial business combination with certain potential target companies if a proposed transaction with the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.
  • I-Bankers may have a conflict of interest in rendering services to us in connection with our initial business combination.
  • We would be subject to a second level of U.S. federal income tax on a portion of our income if we are determined to be a personal holding company (a “PHC”) for U.S. federal income tax purposes.
  • Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.
  • We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time.
  • Our public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares will participate in such vote, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination.
  • If we seek stockholder approval of our initial business combination, our initial stockholders, officers, and directors have agreed to vote in favor of such initial business combination, regardless of how our public stockholders vote.
  • Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash, unless we seek stockholder approval of the business combination.
  • The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
The other 65 risks
  • The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.
  • The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock.
  • The requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination on terms that would optimize value for our stockholders.
  • We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public stockholders may only receive $10.05 per share, or less than such amount in certain circumstances.
  • If we seek stockholder approval of our initial business combination, our initial stockholders, directors, officers, advisors and their affiliates may elect to purchase shares from public stockholders, which may influence a vote on a proposed business combination and reduce the public “float” of our common stock.
  • If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
  • You will not be entitled to protections normally afforded to investors of many other blank check companies.
  • If we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders are deemed to hold 15% or more of our common stock, you will lose the ability to redeem all such shares equal to or in excess of 15% of our common stock.
  • Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.05 per share, on our redemption, and our rights will expire worthless.
  • If the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account are insufficient to allow us to operate for at least the combination period, we may be unable to complete our initial business combination, in which case our public stockholders may only receive $10.05 per share, or less than such amount in certain circumstances, and our rights will expire worthless.
  • If the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account are insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination and we will depend on loans from our sponsor or management team to fund our search, to pay our taxes and to complete our business combination.
  • We may seek acquisition opportunities in companies that may be outside of our management’s areas of expertise.
  • Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.
  • We are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial point of view.
  • Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.05 per share on the liquidation of our trust account and our rights will expire worthless.
  • We may have a limited ability to assess the management of a prospective target business and, as a result, may affect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.
  • We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our initial stockholders, executive officers and directors which may raise potential conflicts of interest.
  • We will likely only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement units, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.
  • We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.
  • We may attempt to complete our initial business combination with a private company about which little information is available, which may result in an initial business combination with a company that is not as profitable as we suspected, if at all.
  • We may reincorporate in another jurisdiction in connection with an initial business combination and such reincorporation may result in taxes imposed on stockholders.
  • Our management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.
  • We do not have a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 both immediately before and after the consummation of our initial business combination. The absence of such a redemption threshold may make it possible for us to complete our initial business combination with which a substantial majority of our stockholders do not agree.
  • We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination.
  • Because we must furnish our stockholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.
  • Our search for an initial business combination, and any target business with which we ultimately consummate an initial business combination, may be materially adversely affected by new outbreaks, or continuation of any existing outbreaks, of any infectious disease (such as COVID-19) and other events, and the status of debt and equity markets.
  • Changes in international trade policies, tariffs and treaties affecting imports and exports may have a material adverse effect on our search for an initial business combination target, our ability to complete an initial business combination, and/or our business, financial condition and results of operations following completion of an initial business combination.
  • Risks Relating to the Post-Business Combination Company
  • Subsequent to the completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our stock price, which could cause you to lose some or all of your investment.
  • Because we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’ operations.
  • We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our stockholders’ investment in us.
  • If we effect our initial business combination with a company with operations or opportunities outside of the United States, we would be subject to a variety of additional risks that may negatively impact our operations.
  • If our management following our initial business combination is unfamiliar with U.S. securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues.
  • Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.
  • Risks Relating to our Management and Directors
  • Past performance by our management team, including investments and transactions which they have participated in and businesses with which they have been associated, may not be indicative of future performance of an investment in us.
  • We are dependent upon our executive officers and directors and their departure could adversely affect our ability to operate.
  • Our ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.
  • Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
  • Our executive officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.
  • Certain of our executive officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us following our initial business combination and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
  • Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
  • Since our initial stockholders, including our sponsor, of which our executive officers and directors are members, will lose its entire investment in us if our initial business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.
  • Since our initial stockholders, executive officers and directors will not be eligible to be reimbursed for their out-of-pocket expenses if our business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.
  • Risks Relating to Our Securities
  • You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares or rights, potentially at a loss.
  • NASDAQ may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.
  • Holders of rights will not have redemption rights.
  • If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by stockholders may be less than $10.05 per share.
  • The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the aggregate value of the assets held in the trust account such that the per share redemption amount received by public stockholders may be less than your anticipated per share redemption amount.
  • Our directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution to our public stockholders.
  • We may not have sufficient funds to satisfy indemnification claims of our directors and officers.
  • If, after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.
  • If, before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our stockholders and the per-share amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.
  • Our stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
  • We may not hold an annual meeting of stockholders until after our consummation of a business combination and you will not be entitled to any of the corporate protections provided by such a meeting.
  • The grant of registration rights to our initial stockholders and holders of our private placement units may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our common stock.
  • We may issue additional shares of common stock or preferred stock to complete our initial business combination or under an employee incentive plan after completion of our initial business combination, and any such issuances would dilute the interest of our stockholders and likely present other risks.
  • In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. We cannot assure you that we will not seek to amend our amended and restated articles of incorporation or governing instruments in a manner that will make it easier for us to complete our initial business combination that our stockholders may not support.
  • Certain agreements related to our initial public offering may be amended without stockholder approval.
  • Our initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you do not support.
  • Our sponsor paid an aggregate of $3,000 for the founder shares, or approximately $0.0009 per founder share. As a result of this low initial price, our initial stockholders, including our sponsor, which includes our management team and advisors, stands to make a substantial profit even if an initial business combination subsequently declines in value or is unprofitable for our public stockholders.
  • We may amend the terms of the rights in a manner that may be adverse to holders of rights with the approval by the holders of at least 65% of the then outstanding rights.
  • Our rights and private placement rights may have an adverse effect on the market price of our common stock and make it more difficult to effectuate our initial business combination.
  • The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.
  • The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our common stock at such time is substantially less than $10.00 per share.
  • The determination of the offering price of our units and the size of our initial public offering is more arbitrary than the pricing of securities and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of such units than you would have in a typical offering of an operating company.
  • Provisions in our amended and restated articles of incorporation and Nevada law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our common stock and could entrench management.

Legal proceedings

To the knowledge of our management, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    SEC EDGAROther events
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31